|
?:abstract
|
-
Coronavirus disease 2019 (COVID-19) is a global pandemic caused by SARS-CoV-2 virus As of the 30th of September 2020, around 34,000,000 cases have been reported globally Pediatrics with underlying congenital heart disease represent a small yet a critical proportion of these patients In general, the majority of infected children experience mild to moderate disease with significant interindividual variability in laboratory and radiographic findings Nevertheless, in healthy children with COVID-19, cardiac involvement has been documented and is attributed to various causes Myocarditis, arrhythmias, cardiogenic shock, and serious multisystem inflammatory syndrome in children are all encountered Since COVID-19 is a recent novel disease and based on previous experience with respiratory infections, children with underlying congenital heart disease should be given special attention To date, little data is available about COVID-19 presentation, complications, and appropriate treatment in this population However, variable and inconsistent disease presentation and severity have been observed This paper discusses COVID-19 course of illness in pediatric population with a special emphasis on the cardiac manifestations of the disease in healthy population and also on the disease course in congenital heart disease patients in particular
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}